Jazz Pharma buys the only shot at a disease with no FDA treatment

Summary

Jazz Pharmaceuticals has acquired a company with a treatment for a disease that currently has no FDA-approved therapies. The acquisition targets an unmet medical need in a therapeutic area without existing treatment options.